BAFNA PHARMA Share Price

₹ 438.95

-₹8.95 (-2%)
1D
Last updated 02 Nov, 2026, 13:14 IST
NSE: BAFNAPH
|
Pharmaceuticals

BAFNA PHARMA Share Price Today

As of 2 Nov 2026, BAFNA PHARMA share price is ₹438.95. The stock opened at ₹438.95, compared to its previous close of ₹447.90. During today's trading session, BAFNA PHARMA share price moved in the range of ₹438.95 to ₹438.95, with an average price of ₹438.95 for the day. Looking at its last 52-week, the stock has touched a low of ₹94.77 and a high of ₹479.95. On the performance front, BAFNA PHARMA share price has increased by 234.25% over the last six months and is up 218.09% on a year-on-year basis.

Share price over the last 1 day rose from 438.95 to 438.95, ranging between 438.95 and 438.95.
₹438.95
2.00% down today
₹438.95
1D LOW
1D HIGH

BAFNA PHARMA Stock Insights

Latest Earning
Op Profit TrendUp by 85.18% QoQ
Latest Earning
Net Profit TrendUp by 72.30% QoQ
Latest Earning
Revenue TrendUp by 70.07% QoQ
Stock Performance
OutperformingBeat Nifty by 18.7 % in last 1 month
BAFNA PHARMA stock performance
Open₹438.95
High₹438.95
Low₹438.95
Prev. close₹447.90
BAFNA PHARMA trading activity
Volume3,331
Average traded price₹438.95
Last traded time01:14:15 02 Nov
Last traded quantity1,000
Circuit
L
H
₹438.95
₹456.85
52-week
L
H
₹94.77
₹479.95
Mkt Cap Cr
1,059.57
P/E
136.14
P/B
-0.49
ROA
-45.61%
ROE
11.54%
ROCE
10.63%
Quick Ratio
1.44
EV/EBITDA
0.16

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Bafna Pharma. outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Bafna Pharma. appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Bafna Pharma. earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

BAFNA PHARMA Company Background

ISIN
INE878I01022
Sector Market Cap
₹ 1,059.57 Cr

Bafna Pharmaceuticals Limited is an India-based company, which is engaged in manufacturing of pharmaceutical formulations. The Company exports its products to the Europe, the United Kingdom, Australia, Sri Lanka, Africa, and Commonwealth countries.

BAFNA PHARMA Financial Highlights

  • Revenue: BAFNA PHARMA reported revenue of ₹44.01 crore in FY19 vs ₹78.50 crore in FY18. It showed a decrease of 43.94% on a yearly basis.
  • Operating Profit: BAFNA PHARMA reported an operating loss of ₹17.28 crore in FY19 vs ₹14.72 crore in FY18. It showed a decrease of 17.39% on a year-on-year basis.
  • Net Profit: BAFNA PHARMA reported a net loss of ₹18.35 crore in FY19 vs ₹16.91 crore in FY18. It showed a decrease of 8.52% on a yearly basis.

BAFNA PHARMA Quarterly Result Highlights

  • BAFNA PHARMA reported revenue of ₹12.16 crore in Sep 2019, compared with ₹7.15 crore in Jun 2019, representing an increase of 70.07% on a quarter-on-quarter (QoQ) basis.
  • BAFNA PHARMA reported an operating loss of ₹0.55 crore in Sep 2019, compared with ₹3.71 crore in Jun 2019, representing an increase of 85.18% on a quarter-on-quarter (QoQ) basis.
  • BAFNA PHARMA reported a loss of ₹0.59 crore in Sep 2019, compared with ₹2.13 crore in Jun 2019, reflecting an increase of 72.30% on a QoQ basis.
  • The earnings per share (EPS) of BAFNA PHARMA stood at ₹15.52 during Sep 2019.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
75.00%
FII
9.34%
Other DII
0.00%
Retail and other
15.66%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20259.34%
Mar 20269.34%
Jun 20269.34%
Sep 20269.34%

BAFNA PHARMA Investment Returns

1 day
-1.99%
1 week
+1.12%
1 month
+20.61%
1 year
+218.09%
3 years
+416.91%
5 years
+267.73%

BAFNA PHARMA Share Price History

BAFNA PHARMA share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹457.00 / ₹447.90
-1.99%
29 Oct 26
₹460.60 / ₹457.00
+1.20%
28 Oct 26
₹451.60 / ₹451.60
+2.00%
27 Oct 26
₹442.75 / ₹442.75
+1.99%
Show more

BAFNA PHARMA Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2020Mar 2019Mar 2018Mar 2017
Revenue₹42.47₹43.63₹47.17₹64.96
Other Income₹0.26₹0.39₹31.33₹1.14
Total Revenue₹42.73₹44.01₹78.50₹66.10
Total Expenses₹44.61₹62.31₹93.22₹86.46
Profit Before Tax-₹1.88-₹18.29-₹14.72-₹20.36
Tax₹0.00₹1.07₹2.19-₹0.90
Profit After Tax-₹1.88-₹19.36-₹16.91-₹19.46
EPS - Basic-₹15.52-₹11.48-₹9.24-₹10.43
EPS - Diluted-₹15.52-₹11.48-₹9.24-₹10.43

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2020Mar 2019Mar 2018Mar 2017
Profit before tax-₹1.88-₹18.29-₹14.72-₹20.36
Income before WC changes-₹21.34-₹12.84-₹34.24-₹4.86
Change in Assets₹18.14₹0.03₹28.74₹15.55
Change in Liabilities-₹31.11₹11.03-₹1.54-₹11.64
Change in WC-₹12.97₹11.06₹27.20₹3.91
Cash flow from Operations-₹34.31-₹1.79-₹7.05-₹0.95
Cash flow from Investing₹32.77₹15.36₹37.97-₹5.42
Cash flow from Financing₹7.30-₹13.81-₹30.63₹6.31
Total Cash Flow₹5.77-₹0.24₹0.29-₹0.06
Cash (Start of the year)₹2.71₹2.95₹2.66₹2.71
Cash (End of the year)₹8.48₹2.71₹2.95₹2.66

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2020Mar 2019Mar 2018Mar 2017
Non-Current Assets₹35.22₹71.00₹89.62₹101.12
Current Assets₹36.10₹48.47₹48.74₹77.18
Total Assets₹71.31₹119.47₹138.36₹178.31
Current Liabilities₹17.10₹70.82₹59.85₹81.47
Net Current Asset₹19.00-₹22.35-₹11.11-₹4.29
Non-Current Liabilities₹3.02₹29.80₹41.31₹54.72
Equity Capital₹51.20₹18.85₹37.20₹42.11
Total Equity & Liabilities₹71.31₹119.47₹138.36₹178.31

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹150.62₹145.86₹152.47₹115.35
Other Income₹4.76₹2.74₹3.52₹3.27
Total Revenue₹155.37₹148.60₹155.99₹118.62
Total Expenses₹144.40₹142.30₹148.64₹107.01
Profit Before Tax₹10.97₹4.15₹7.35₹11.62
Tax-₹0.13₹0.00₹0.00₹0.28
Profit After Tax₹11.10₹4.15₹7.35₹11.34
EPS - Basic₹4.69₹1.76₹3.11₹4.79
EPS - Diluted₹4.69₹1.76₹3.11₹4.79

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹10.97₹4.15₹7.35₹11.62
Income before WC changes₹20.65₹14.24₹14.94₹19.50
Change in Assets-₹5.43₹10.47-₹14.19-₹30.15
Change in Liabilities-₹0.17-₹2.92₹8.91₹15.73
Change in WC-₹5.60₹7.55-₹5.28-₹14.42
Cash flow from Operations₹15.37₹22.14₹9.48₹4.95
Cash flow from Investing-₹22.40-₹21.16-₹15.05-₹7.49
Cash flow from Financing₹5.62₹1.06-₹0.85₹10.18
Total Cash Flow-₹1.41₹2.04-₹6.41₹7.64
Cash (Start of the year)₹3.43₹1.40₹7.81₹0.17
Cash (End of the year)₹2.02₹3.43₹1.40₹7.81

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹85.88₹68.35₹53.91₹42.27
Current Assets₹89.65₹84.73₹93.77₹87.31
Total Assets₹175.53₹153.08₹147.68₹129.58
Current Liabilities₹57.19₹51.85₹54.08₹46.48
Net Current Asset₹32.46₹32.88₹39.69₹40.84
Non-Current Liabilities₹22.19₹16.42₹12.76₹9.65
Equity Capital₹96.15₹84.81₹80.84₹73.45
Total Equity & Liabilities₹175.53₹153.08₹147.68₹129.58
* All values are in INR Crore
BAFNA PHARMA market depth
Bid quantityBid priceAsk priceAsk quantity
56438.95438.956828
00447.925
00456275
00456.85307
0000
Total bid quantity56
Total ask quantity7,435
BAFNA PHARMA technical summary
Bearish indicators1
Neutral indicators5
Bullish indicators2
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
67.05
Neutral
ATR (14)
9.57
Neutral
STOCH(9,6)
30.1
Neutral
STOCH RSI (14)
1.51
Bullish
ADX(9)
53.32
Bearish
UO(9)
47.7
Neutral
ROC(12)
3
Bullish
WillR(14)
-59.79
Neutral
Period
Simple value
Exponential vaue
5D
446.67
449.41
10D
452.13
445.52
20D
433.36
427.1
50D
356.48
370.94
100D
288.82
308.78
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
26 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

BAFNA PHARMA
Pharmaceuticals
Add Stock
Add Another

BAFNA PHARMA Returns Calculator

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹291.50
+39.65 (+15.74%)
PRAJIND Share Price
₹269.87
+28.17 (+11.65%)
DIXON Share Price
₹12280.00
+1280 (+11.64%)
MSUMI Share Price
₹39.05
+3.91 (+11.13%)
See more

Top Losers

INDIGOPNTS Share Price
₹880.00
-117.3 (-11.76%)
CLEAN Share Price
₹665.85
-49.75 (-6.95%)
ZEEL Share Price
₹61.97
-4.43 (-6.67%)
POLICYBZR Share Price
₹934.00
-66.1 (-6.61%)
SYRMA Share Price
₹1528.30
-97 (-5.97%)
See more

BAFNA PHARMA Share Price FAQs

Please be aware that BAFNA PHARMA stock prices are subject to continuous fluctuations due to various factors.